All In Biotech

Drug Trial Radar · NCT00004064

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

A Randomized, Double-Blind, Placebo-Controlled, Phase IIB Study of the Safety and Efficacy of OVAREX MabB43.13 in Ovarian Cancer Patients With an Elevated Serum CA 125 But Without Other Evidence of Disease

Last checked: Nov 19, 2026Latest source record: Nov 6, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 102 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

102

Planned (sponsor's estimate)

Start

Nov 1998

Primary completion

Not stated

Sponsor

Lead sponsor
AltaRexIndustry
Sponsor type
Industry
First posted
Aug 5, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Randomized phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have ovarian, fallopian tube, or peritoneal cancer.

Conditions

  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer

Interventions

  • oregovomabBiological

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

16 sites in 2 countries. Site status is shown where the registry gives one.

  • Gynecologic Oncology Associates

    Newport Beach, California

  • Lee Memorial Health System

    Fort Myers, Florida

  • Walt Disney Memorial Cancer Institute

    Orlando, Florida

  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida

  • Indiana University Cancer Center

    Indianapolis, Indiana

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Mercy Medical Center, Inc.

    Baltimore, Maryland

  • Barnes-Jewish Hospital

    St Louis, Missouri

  • St. John's Mercy Medical Center

    St Louis, Missouri

  • University of Oklahoma College of Medicine

    Oklahoma City, Oklahoma

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania

  • Palmetto Richland Memorial Hospital

    Columbia, South Carolina

  • Texas Oncology, P.A.

    Dallas, Texas

  • Cancer Center, University of Virginia HSC

    Charlottesville, Virginia

  • Riverside Regional Medical Center

    Newport News, Virginia

  • Ottawa Regional Cancer Center - General Division

    Ottawa, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.